Dietary trial in prostate cancer: Early experience and implications for clinical trial design

Urology

Volumn 57, Issue 4 SUPPL. 1, 2001, Pages 200-201

  Ornish, Dean M ^a,b   Lee, Keith L ^b   Fair, William R ^c   Pettengill, Elaine B ^a   Carroll, Peter R ^b  

^a Preventive Medicine Research Institute   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; EXERCISE; FAT INTAKE; HUMAN; LIFESTYLE; MALE; PATHOLOGY; PROSPECTIVE STUDY; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SELF HELP; STRESS; VEGETARIAN DIET;

DIET, VEGETARIAN; DIETARY FATS; EXERCISE; HUMANS; LIFE STYLE; MALE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; SELF-HELP GROUPS; STRESS;

EID: 0035316857     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0090-4295(00)00974-2     Document Type: Article

References (9)

1. Fair WR: Willet F. Whitore, Jr. Lecture: back to the future - the role of complementary medicine in urology [review]. J Urol 162(2): 411-420, 1999.
2. Parkin DM, Pisani P, and Ferlay J: Global cancer statistics. CA Cancer J Clin 49(1): 33-64, 1999.
3. Hebert JR, Hurley JR, Olendzki BC, et al: Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J Natl Cancer Inst 90(21): 1637-1647, 1998.
4. Shimizu H, Ross RK, Bernstein L, et al: Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63(6): 963-966, 1991.
5. Wang Y, Corr JG, Thaler HT, et al: Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 87(19): 1456-1462, 1995.
6. Chan JM, Stampfer MJ, Giovannucci E, et al: Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279: 563-566, 1998.
7. Grossfeld GD, Olumi AF, Connolly JA, et al: Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity. J Urol 159(5): 1437-1443, 1998.
8. Keshgegian AA, Johnston E, and Cnaan A: Bcl-2 oncoprotein positivity and high MIB-1 (Ki-67) proliferative rate are independent predictive markers for recurrence in prostate carcinoma. Am J Clin Pathol 110(4): 443-449, 1998.
9. Gann PH, Hennekens C, Ma J, et al: Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 88(16): 1118-1126, 1996.